Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NGAL Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF

NCT00693745 is registered in ClinicalTrials.gov with Abbott RDx Cardiometabolic as lead sponsor.

NCT NCT00693745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00693745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NGAL Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF
Lead sponsor
Abbott RDx Cardiometabolic
Phase
Observational
Overall status
Completed
Start date
September 30, 2008
Completion date
July 31, 2010
Enrollment
231 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure